SEC Form 4 · accession 0001140361-15-041230
TENET HEALTHCARE CORP · THC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Nov 11, 2015
Accepted (ET)
Nov 13, 2015 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070318
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.05 par valueF1,F3,F2 | Nov 11, 2015 | P | 500,000 | $32.8588 | A | 17,490,230 | I | See footnotes 1 and 2 |
| Common Stock, $0.05 par valueF1,F4,F2 | Nov 12, 2015 | P | 250,000 | $32.2778 | A | 17,740,230 | I | See footnotes 1 and 2 |
| Common Stock, $0.05 par valueF1,F5,F2 | Nov 13, 2015 | P | 150,000 | $32.0122 | A | 17,890,230 | I | See footnotes 1 and 2 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were purchased for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.
- F2Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F3This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on November 11, 2015 within a $1.00 range. The actual prices for these transactions range from $32.515 to $33.025, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- F4This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on November 12, 2015 within a $1.00 range. The actual prices for these transactions range from $31.99 to $32.395, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- F5This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on November 13, 2015 within a $1.00 range. The actual prices for these transactions range from $31.805 to $32.22, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Remarks
Exhibit List: The Power of Attorney filed as Exhibit B to the Schedule 13G/A filed by the Reporting Persons on November 13, 2015 is incorporated herein by reference.